{"DataElement":{"publicId":"10369482","version":"1","preferredName":"Pharmacologic Substance Smoking Cessation Intervention Use Type","preferredDefinition":"A person's response about the type of pharmacological smoking cessation interventions they have used.","longName":"10369481v1.00:10369479v1.00","context":"AMC","contextVersion":"1","DataElementConcept":{"publicId":"10369481","version":"1","preferredName":"Pharmacologic Substance Smoking Cessation Intervention Use","preferredDefinition":"Any natural, endogenously-derived, synthetic or semi-synthetic compound with pharmacologic activity. A pharmacologic substance has one or more specific mechanism of action(s) through which it exerts one or more effect(s) on the human or animal body. They can be used to potentially prevent, diagnose, treat or relieve symptoms of a disease. Formulation specific agents and some combination agents are also classified as pharmacologic substances._Any intervention designed to reduce and eliminate an individual's smoking.:A manner, or usual, or accepted practice of using something.","longName":"10369480v1.00:2234899v1.00","context":"AMC","contextVersion":"1","ObjectClass":{"publicId":"10369480","version":"1","preferredName":"Pharmacologic Substance Smoking Cessation Intervention","preferredDefinition":"Any natural, endogenously-derived, synthetic or semi-synthetic compound with pharmacologic activity. A pharmacologic substance has one or more specific mechanism of action(s) through which it exerts one or more effect(s) on the human or animal body. They can be used to potentially prevent, diagnose, treat or relieve symptoms of a disease. Formulation specific agents and some combination agents are also classified as pharmacologic substances._No value exists.","longName":"C1909:C15372","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pharmacologic Substance","conceptCode":"C1909","definition":"Any natural, endogenously-derived, synthetic or semi-synthetic compound with pharmacologic activity. A pharmacologic substance has one or more specific mechanism of action(s) through which it exerts one or more effect(s) on the human or animal body. They can be used to potentially prevent, diagnose, treat or relieve symptoms of a disease. Formulation specific agents and some combination agents are also classified as pharmacologic substances.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Smoking Cessation Intervention","conceptCode":"C15372","definition":"Any intervention designed to reduce and eliminate an individual's smoking.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DFC126EC-18E8-3073-E053-731AD00A1C5A","latestVersionIndicator":"Yes","beginDate":"2022-05-25","endDate":null,"createdBy":"TSESU","dateCreated":"2022-05-25","modifiedBy":"TSESU","dateModified":"2022-05-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2234899","version":"1","preferredName":"Use","preferredDefinition":"Use; put into service; make work or employ (something) for a particular purpose or for its inherent or natural purpose.","longName":"C25340","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Use","conceptCode":"C25340","definition":"A manner, or usual, or accepted practice of using something.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F9860F29-7486-7421-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-15","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-06-15","modifiedBy":"ONEDATA","dateModified":"2005-06-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2524082","version":"1","preferredName":"Person Measure/Instrument Testing","preferredDefinition":"Process and results associated with self-reported measures and instruments, surveys, other tools","longName":"MEASURE/INSTRUMENT TESTING","context":"CCR","contextVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"1E838B40-6636-0A25-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-09-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-09-28","modifiedBy":"REEVESD","dateModified":"2008-11-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DFC126EC-18E9-3073-E053-731AD00A1C5A","latestVersionIndicator":"Yes","beginDate":"2022-05-25","endDate":null,"createdBy":"TSESU","dateCreated":"2022-05-25","modifiedBy":"KUMMEROA","dateModified":"2023-09-15","changeDescription":null,"administrativeNotes":"2023.9.15 Updated def for 'No Value Exists'. ak","unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"10369479","version":"1","preferredName":"Pharmacologic Substance Smoking Cessation Intervention Type","preferredDefinition":"Any natural, endogenously-derived, synthetic or semi-synthetic compound with pharmacologic activity. A pharmacologic substance has one or more specific mechanism of action(s) through which it exerts one or more effect(s) on the human or animal body. They can be used to potentially prevent, diagnose, treat or relieve symptoms of a disease. Formulation specific agents and some combination agents are also classified as pharmacologic substances._Any intervention designed to reduce and eliminate an individual's smoking._Something distinguishable as an identifiable class based on common qualities.","longName":"10369479v1.00","context":"AMC","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"35","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Varenicline","valueDescription":null,"ValueMeaning":{"publicId":"7130499","version":"1","preferredName":"Varenicline","longName":"7130499","preferredDefinition":"A partial agonist of the nicotinic acetylcholine receptor (nAChR) subtype alpha4beta2. Nicotine stimulation of central alpha4beta2 nAChRs located at presynaptic terminals in the nucleus accumbens causes the release of the neurotransmitter dopamine, which may be associated with the experience of pleasure; nicotine addiction constitutes a physiologic dependence related to this dopaminergic reward system. As an AChR partial agonist, varenicline attenuates the craving and withdrawal symptoms that occur with abstinence from nicotine but is not habit-forming itself.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Varenicline","conceptCode":"C73609","definition":"A partial agonist of the nicotinic acetylcholine receptor (nAChR) subtype alpha4beta2. Nicotine stimulation of central alpha4beta2 nAChRs located at presynaptic terminals in the nucleus accumbens causes the release of the neurotransmitter dopamine, which may be associated with the experience of pleasure; nicotine addiction constitutes a physiologic dependence related to this dopaminergic reward system. As an AChR partial agonist, varenicline attenuates the craving and withdrawal symptoms that occur with abstinence from nicotine but is not habit-forming itself.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9BA5935F-F632-2EF6-E053-F662850A9D24","latestVersionIndicator":"Yes","beginDate":"2020-01-09","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-01-09","modifiedBy":"ONEDATA","dateModified":"2020-01-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DFC126EC-18E5-3073-E053-731AD00A1C5A","beginDate":"2022-05-25","endDate":null,"createdBy":"TSESU","dateCreated":"2022-05-25","modifiedBy":"TSESU","dateModified":"2022-05-25","deletedIndicator":"No"},{"value":"Bupropion","valueDescription":null,"ValueMeaning":{"publicId":"5285212","version":"1","preferredName":"Bupropion","longName":"5285212","preferredDefinition":"An aminoketone with antidepressant activity. The molecular mechanism of the antidepressant effect of bupropion is unknown.  This agent does not inhibit monoamine oxidase and, compared to classical tricyclic antidepressants, is a weak blocker of the neuronal uptake of serotonin and norepinephrine. Buproprion also weakly inhibits the neuronal re-uptake of dopamine.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Bupropion","conceptCode":"C62012","definition":"An aminoketone with antidepressant activity. The molecular mechanism of the antidepressant effect of bupropion is unknown.  This agent does not inhibit monoamine oxidase and, compared to classical tricyclic antidepressants, is a weak blocker of the neuronal uptake of serotonin and norepinephrine. Buproprion also weakly inhibits the neuronal re-uptake of dopamine.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"345FC402-A866-DE13-E050-BB89AD434D33","latestVersionIndicator":"Yes","beginDate":"2016-06-03","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-06-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DFC126EC-18E6-3073-E053-731AD00A1C5A","beginDate":"2022-05-25","endDate":null,"createdBy":"TSESU","dateCreated":"2022-05-25","modifiedBy":"TSESU","dateModified":"2022-05-25","deletedIndicator":"No"},{"value":"Not applicable","valueDescription":null,"ValueMeaning":{"publicId":"2581003","version":"1","preferredName":"Not applicable","longName":"2581003v1.00","preferredDefinition":"Determination of a value is not relevant in the current context.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Not Applicable","conceptCode":"C48660","definition":"Determination of a value is not relevant in the current context.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0978-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-12-31","endDate":null,"createdBy":"SBREXT","dateCreated":"2003-12-31","modifiedBy":"CLOHNES","dateModified":"2023-11-09","changeDescription":null,"administrativeNotes":"2023.3.6 Added Alt VM-COG. ak","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DFC126EC-18E7-3073-E053-731AD00A1C5A","beginDate":"2022-05-25","endDate":null,"createdBy":"TSESU","dateCreated":"2022-05-25","modifiedBy":"TSESU","dateModified":"2022-05-25","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2524082","version":"1","preferredName":"Person Measure/Instrument Testing","preferredDefinition":"Process and results associated with self-reported measures and instruments, surveys, other tools","longName":"MEASURE/INSTRUMENT TESTING","context":"CCR","contextVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"1E838B40-6636-0A25-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-09-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-09-28","modifiedBy":"REEVESD","dateModified":"2008-11-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"10369478","version":"1","preferredName":"Pharmacologic Substance Smoking Cessation Intervention Type","preferredDefinition":"Any natural, endogenously-derived, synthetic or semi-synthetic compound with pharmacologic activity. A pharmacologic substance has one or more specific mechanism of action(s) through which it exerts one or more effect(s) on the human or animal body. They can be used to potentially prevent, diagnose, treat or relieve symptoms of a disease. Formulation specific agents and some combination agents are also classified as pharmacologic substances._No value exists._Something distinguishable as an identifiable class based on common qualities.","longName":"10369478v1.00","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pharmacologic Substance","conceptCode":"C1909","definition":"Any natural, endogenously-derived, synthetic or semi-synthetic compound with pharmacologic activity. A pharmacologic substance has one or more specific mechanism of action(s) through which it exerts one or more effect(s) on the human or animal body. They can be used to potentially prevent, diagnose, treat or relieve symptoms of a disease. Formulation specific agents and some combination agents are also classified as pharmacologic substances.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Smoking Cessation Intervention","conceptCode":"C15372","definition":"Any intervention designed to reduce and eliminate an individual's smoking.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DFC126EC-18E3-3073-E053-731AD00A1C5A","latestVersionIndicator":"Yes","beginDate":"2022-05-25","endDate":null,"createdBy":"TSESU","dateCreated":"2022-05-25","modifiedBy":"TSESU","dateModified":"2022-05-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DFC126EC-18E4-3073-E053-731AD00A1C5A","latestVersionIndicator":"Yes","beginDate":"2022-05-25","endDate":null,"createdBy":"TSESU","dateCreated":"2022-05-25","modifiedBy":"KUMMEROA","dateModified":"2023-09-19","changeDescription":null,"administrativeNotes":"2023.9.19 Updated def for 'No Value Exists'. ak","unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[{"name":"PSMCTYP_CMTRT","type":"OID, AMC","context":"AMC"}],"ReferenceDocuments":[{"name":"If ‘Yes', which of the following pharmacologic smoking cessation interventions have you used?","type":"Preferred Question Text","description":"If ‘Yes', which of the following pharmacologic smoking cessation interventions have you used?","url":null,"context":"AMC"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DFC126EC-18EA-3073-E053-731AD00A1C5A","latestVersionIndicator":"Yes","beginDate":"2022-05-25","endDate":null,"createdBy":"TSESU","dateCreated":"2022-05-25","modifiedBy":"TSESU","dateModified":"2022-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}